izpis_h1_title_alt

Cervical intraepithelial neoplasia grade 3 in a HPV-vaccinated patient : a case report
ID Sladič, Mateja (Avtor), ID Taneska, Pepita (Avtor), ID Cvjetičanin, Branko (Avtor), ID Velikonja, Mojca (Avtor), ID Smrkolj, Vladimir (Avtor), ID Smrkolj, Špela (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (16,44 MB)
MD5: 1104256810D8CD244FC108B6C39EE512
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1648-9144/58/3/339 Povezava se odpre v novem oknu

Izvleček
Persistent infection with human papillomavirus (HPV) causes almost all cervical precancerous lesions and cancers. Bivalent, quadrivalent, and nonavalent HPV vaccines effectively prevent high-grade cervical intraepithelial neoplasia (CIN3). The effectiveness of HPV vaccination against CIN3 is 97–100% in HPV-naïve populations and 44–61% in the overall population. Although HPV vaccination has substantially reduced the incidence of cervical cancers, several cases of precancerous cervical lesions in HPV-vaccinated patients have been reported. We report the clinical case of a 19-year-old woman whose first Pap smear was diagnosed as a high-grade squamous intraepithelial lesion (HSIL) after quadrivalent HPV vaccination. Colposcopy and cervical biopsy were performed, revealing HSIL/CIN3. Our multidisciplinary team decided to take a conservative approach with follow-up visits with cervical biopsies of this young patient. After six months, spontaneous regression of high-grade cervical dysplasia was observed. Although HPV immunization has shown to be extremely effective in preventing a high proportion of cervical precancerous lesions and cervical cancers, HPV vaccines do not protect against all oncogenic high-risk HPV genotypes. Consequently, healthcare providers must encourage HPV-vaccinated women to still regularly attend national cervical screening programs.

Jezik:Angleški jezik
Ključne besede:papillomavirus vaccines, Papanicolaou test, cervical intraepithelial neoplasia
Vrsta gradiva:Članek v reviji
Tipologija:1.03 - Kratki znanstveni prispevek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2022
Št. strani:7 str.
Številčenje:Vol. 58, iss. 3, art. 339
PID:20.500.12556/RUL-137257 Povezava se odpre v novem oknu
UDK:618.1
ISSN pri članku:1648-9144
DOI:10.3390/medicina58030339 Povezava se odpre v novem oknu
COBISS.SI-ID:98924803 Povezava se odpre v novem oknu
Datum objave v RUL:08.06.2022
Število ogledov:462
Število prenosov:74
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Medicina
Založnik:MDPI
ISSN:1648-9144
COBISS.SI-ID:6754623 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:01.03.2022

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:cepljenje proti papilomavirusu, maternični vrat, rak materničnega vratu, intraepitelna neoplazija, ginekologija

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj